ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Invega 3 mg, Retardtabletten - 28 Tablette(n)
57961001 Janssen-Cilag AG
Invega 3 mg, Retardtabletten15.05.2008
Original15.05.2008
Paliperidone (N05AX13) 
WHO-DDD 
01.05.28 Tablette(n)
01.05. 
B  
Yes 
IPCI
112.31No
    
10 %137.50
  
7680579610010Synthetika
3786627 
Composition
paliperidonum 3 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum K 29-32, acidum stearicum, E 172 (rubrum), E 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, lactosum monohydricum 13.2 mg, triacetinum, cera carnauba, E 171, Drucktinte: hypromellosum, propylenglycolum, E 172 (nigrum), pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Paliperidonum3 mg
BAG: Active AgentDose
Paliperidonum3 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Acidum Stearicum  
Cellulosi Acetas  
Cera Carnauba  
E 171 color.
E 172 color.
E 321 color.
Hydroxyethylcellulosum Überzug
Hypromellosum Drucktinte
Lactose Monohydrate13.2 mg 
Macrogol3350  
Sodium Chloride  
Polyethyleni Oxidum  
Povidonum K29-32 
Pro Compresso Obducto  
Propylenglycol  
Triacetinum  
 
Source
Data was imported : 07.12.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home